Loading...
Treosulfan Exposure Predicts Thalassemia-Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation
A toxicity-reduced conditioning regimen with treosulfan, fludarabine, and thiotepa in patients with high-risk β-thalassemia major has significantly improved hematopoietic stem cell transplantation (HCT) outcomes. However, complications resulting from regimen-related toxicities (RRTs), mixed chimeris...
Saved in:
| Published in: | Clin Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2024
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7615782/ https://ncbi.nlm.nih.gov/pubmed/37846495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.3078 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|